1. Home
  2. LNTH vs VEON Comparison

LNTH vs VEON Comparison

Compare LNTH & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • VEON
  • Stock Information
  • Founded
  • LNTH 1956
  • VEON 1992
  • Country
  • LNTH United States
  • VEON United Arab Emirates
  • Employees
  • LNTH N/A
  • VEON N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • VEON Telecommunications Equipment
  • Sector
  • LNTH Health Care
  • VEON Telecommunications
  • Exchange
  • LNTH Nasdaq
  • VEON Nasdaq
  • Market Cap
  • LNTH 3.8B
  • VEON 3.5B
  • IPO Year
  • LNTH 2015
  • VEON 1996
  • Fundamental
  • Price
  • LNTH $52.93
  • VEON $48.18
  • Analyst Decision
  • LNTH Buy
  • VEON Strong Buy
  • Analyst Count
  • LNTH 6
  • VEON 4
  • Target Price
  • LNTH $74.17
  • VEON $73.25
  • AVG Volume (30 Days)
  • LNTH 1.2M
  • VEON 106.3K
  • Earning Date
  • LNTH 11-06-2025
  • VEON 11-10-2025
  • Dividend Yield
  • LNTH N/A
  • VEON N/A
  • EPS Growth
  • LNTH N/A
  • VEON N/A
  • EPS
  • LNTH 2.39
  • VEON 8.21
  • Revenue
  • LNTH $1,525,933,000.00
  • VEON $4,226,000,000.00
  • Revenue This Year
  • LNTH N/A
  • VEON $10.11
  • Revenue Next Year
  • LNTH $1.98
  • VEON $7.76
  • P/E Ratio
  • LNTH $22.15
  • VEON $5.90
  • Revenue Growth
  • LNTH 1.95
  • VEON 6.85
  • 52 Week Low
  • LNTH $47.25
  • VEON $30.20
  • 52 Week High
  • LNTH $111.29
  • VEON $64.00
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 44.38
  • VEON 46.80
  • Support Level
  • LNTH $50.16
  • VEON $46.92
  • Resistance Level
  • LNTH $55.55
  • VEON $51.50
  • Average True Range (ATR)
  • LNTH 2.69
  • VEON 2.24
  • MACD
  • LNTH -0.40
  • VEON 0.23
  • Stochastic Oscillator
  • LNTH 24.18
  • VEON 58.48

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.

Share on Social Networks: